231 related articles for article (PubMed ID: 16624246)
1. Inhibition of indoleamine 2,3 dioxygenase activity by H2O2.
Poljak A; Grant R; Austin CJ; Jamie JF; Willows RD; Takikawa O; Littlejohn TK; Truscott RJ; Walker MJ; Sachdev P; Smythe GA
Arch Biochem Biophys; 2006 Jun; 450(1):9-19. PubMed ID: 16624246
[TBL] [Abstract][Full Text] [Related]
2. The selenazal drug ebselen potently inhibits indoleamine 2,3-dioxygenase by targeting enzyme cysteine residues.
Terentis AC; Freewan M; Sempértegui Plaza TS; Raftery MJ; Stocker R; Thomas SR
Biochemistry; 2010 Jan; 49(3):591-600. PubMed ID: 20000778
[TBL] [Abstract][Full Text] [Related]
3. Highlights at the gate of tryptophan catabolism: a review on the mechanisms of activation and regulation of indoleamine 2,3-dioxygenase (IDO), a novel target in cancer disease.
Macchiarulo A; Camaioni E; Nuti R; Pellicciari R
Amino Acids; 2009 Jul; 37(2):219-29. PubMed ID: 18612775
[TBL] [Abstract][Full Text] [Related]
4. Oxidation of L-tryptophan in biology: a comparison between tryptophan 2,3-dioxygenase and indoleamine 2,3-dioxygenase.
Rafice SA; Chauhan N; Efimov I; Basran J; Raven EL
Biochem Soc Trans; 2009 Apr; 37(Pt 2):408-12. PubMed ID: 19290871
[TBL] [Abstract][Full Text] [Related]
5. Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway.
Ball HJ; Yuasa HJ; Austin CJ; Weiser S; Hunt NH
Int J Biochem Cell Biol; 2009 Mar; 41(3):467-71. PubMed ID: 18282734
[TBL] [Abstract][Full Text] [Related]
6. Molecular evidence that melatonin is enzymatically oxidized in a different manner than tryptophan: investigations with both indoleamine 2,3-dioxygenase and myeloperoxidase.
Ferry G; Ubeaud C; Lambert PH; Bertin S; Cogé F; Chomarat P; Delagrange P; Serkiz B; Bouchet JP; Truscott RJ; Boutin JA
Biochem J; 2005 May; 388(Pt 1):205-15. PubMed ID: 15636586
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure and mechanism of tryptophan 2,3-dioxygenase, a heme enzyme involved in tryptophan catabolism and in quinolinate biosynthesis.
Zhang Y; Kang SA; Mukherjee T; Bale S; Crane BR; Begley TP; Ealick SE
Biochemistry; 2007 Jan; 46(1):145-55. PubMed ID: 17198384
[TBL] [Abstract][Full Text] [Related]
8. Interactions between nitric oxide and indoleamine 2,3-dioxygenase.
Samelson-Jones BJ; Yeh SR
Biochemistry; 2006 Jul; 45(28):8527-38. PubMed ID: 16834326
[TBL] [Abstract][Full Text] [Related]
9. Indoleamine 2,3-dioxygenase, tumor-induced tolerance and counter-regulation.
Munn DH
Curr Opin Immunol; 2006 Apr; 18(2):220-5. PubMed ID: 16460921
[TBL] [Abstract][Full Text] [Related]
10. Biochemical and medical aspects of the indoleamine 2,3-dioxygenase-initiated L-tryptophan metabolism.
Takikawa O
Biochem Biophys Res Commun; 2005 Dec; 338(1):12-9. PubMed ID: 16176799
[TBL] [Abstract][Full Text] [Related]
11. Discovery of potent competitive inhibitors of indoleamine 2,3-dioxygenase with in vivo pharmacodynamic activity and efficacy in a mouse melanoma model.
Yue EW; Douty B; Wayland B; Bower M; Liu X; Leffet L; Wang Q; Bowman KJ; Hansbury MJ; Liu C; Wei M; Li Y; Wynn R; Burn TC; Koblish HK; Fridman JS; Metcalf B; Scherle PA; Combs AP
J Med Chem; 2009 Dec; 52(23):7364-7. PubMed ID: 19507862
[TBL] [Abstract][Full Text] [Related]
12. Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2.
Bakmiwewa SM; Fatokun AA; Tran A; Payne RJ; Hunt NH; Ball HJ
Bioorg Med Chem Lett; 2012 Dec; 22(24):7641-6. PubMed ID: 23122865
[TBL] [Abstract][Full Text] [Related]
13. Substrate Oxidation by Indoleamine 2,3-Dioxygenase: EVIDENCE FOR A COMMON REACTION MECHANISM.
Booth ES; Basran J; Lee M; Handa S; Raven EL
J Biol Chem; 2015 Dec; 290(52):30924-30. PubMed ID: 26511316
[TBL] [Abstract][Full Text] [Related]
14. Malaria parasite induces tryptophan-related immune suppression in mice.
Tetsutani K; To H; Torii M; Hisaeda H; Himeno K
Parasitology; 2007 Jul; 134(Pt 7):923-30. PubMed ID: 17316473
[TBL] [Abstract][Full Text] [Related]
15. Redox and spectroscopic properties of human indoleamine 2,3-dioxygenase and a His303Ala variant: implications for catalysis.
Papadopoulou ND; Mewies M; McLean KJ; Seward HE; Svistunenko DA; Munro AW; Raven EL
Biochemistry; 2005 Nov; 44(43):14318-28. PubMed ID: 16245948
[TBL] [Abstract][Full Text] [Related]
16. Novel indoleamine 2,3-dioxygenase-1 inhibitors from a multistep in silico screen.
Smith JR; Evans KJ; Wright A; Willows RD; Jamie JF; Griffith R
Bioorg Med Chem; 2012 Feb; 20(3):1354-63. PubMed ID: 22112538
[TBL] [Abstract][Full Text] [Related]
17. Bimodal effect of nitric oxide in the enzymatic activity of indoleamine 2,3-dioxygenase in human monocytic cells.
López AS; Alegre E; Díaz A; Mugueta C; González A
Immunol Lett; 2006 Aug; 106(2):163-71. PubMed ID: 16797727
[TBL] [Abstract][Full Text] [Related]
18. In vitro modulation of cytochrome P450 reductase supported indoleamine 2,3-dioxygenase activity by allosteric effectors cytochrome b(5) and methylene blue.
Pearson JT; Siu S; Meininger DP; Wienkers LC; Rock DA
Biochemistry; 2010 Mar; 49(12):2647-56. PubMed ID: 20178337
[TBL] [Abstract][Full Text] [Related]
19. Comment on "Reduced cytotoxic function of effector CD8+ T cells is responsible for indoleamine 2,3-dioxygenase-dependent immune suppression".
Sørensen RB; thor Straten P; Andersen MH
J Immunol; 2009 Nov; 183(10):6040. PubMed ID: 19890063
[No Abstract] [Full Text] [Related]
20. Human tryptophan dioxygenase: a comparison to indoleamine 2,3-dioxygenase.
Batabyal D; Yeh SR
J Am Chem Soc; 2007 Dec; 129(50):15690-701. PubMed ID: 18027945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
